![Gary Patou](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Gary Patou
Director/Board Member at XENON PHARMACEUTICALS INC.
Net worth: 1 M $ as of 2024-05-30
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Ian Mortimer | M | 48 | 11 years | |
Adam Rosenthal | M | - |
True North Therapeutics, Inc.
![]() True North Therapeutics, Inc. BiotechnologyHealth Technology True North Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of first-in-class product candidates for complement-mediated diseases. The company was founded by Nancy E. Stagliano in 2013 and is headquartered in South San Francisco, CA.
Star Therapeutics, Inc.
![]() Star Therapeutics, Inc. BiotechnologyHealth Technology Star Therapeutics, Inc. is an American company that aims to develop life-changing therapies for rare diseases. The company's mission is to help millions of patients in urgent need. The company was founded by Adam Rosenthal, who has been the CEO since incorporation. | 6 years |
Nancy E. Stagliano | M | 57 |
True North Therapeutics, Inc.
![]() True North Therapeutics, Inc. BiotechnologyHealth Technology True North Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of first-in-class product candidates for complement-mediated diseases. The company was founded by Nancy E. Stagliano in 2013 and is headquartered in South San Francisco, CA.
Star Therapeutics, Inc.
![]() Star Therapeutics, Inc. BiotechnologyHealth Technology Star Therapeutics, Inc. is an American company that aims to develop life-changing therapies for rare diseases. The company's mission is to help millions of patients in urgent need. The company was founded by Adam Rosenthal, who has been the CEO since incorporation. | 11 years |
Kristen Laguerre | F | - |
MPM BioImpact, Inc
![]() MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | 7 years |
Gary J. Bennett | M | - |
Biointervene, Inc.
![]() Biointervene, Inc. Pharmaceuticals: MajorHealth Technology Biointervene, Inc. operates as a biopharmaceutical company. The company was founded by Gary J. Bennett and Daniela Salvemini in 2014 and is headquartered in San Diego, CA. | - |
Kristen Williams | F | 50 | 13 years | |
Luke Evnin | M | 60 |
Scleroderma Research Foundation
![]() Scleroderma Research Foundation BiotechnologyHealth Technology The Scleroderma Research Foundation is a non-profit organization that funds research for scleroderma, a potentially life-threatening illness. The non-profit company is based in San Francisco, CA. Established in 1987 by a patient-turned-activist, the foundation is the largest investor in scleroderma research. The foundation's goal is to find a cure for the disease by bringing together the best minds in science. The SRF has invested over $39 million dollars to date in scleroderma research, funding and facilitating research at top institutions such as Johns Hopkins University School of Medicine, Stanford University, and the University of California. | 22 years |
Carl Gordon | M | 59 |
Star Therapeutics, Inc.
![]() Star Therapeutics, Inc. BiotechnologyHealth Technology Star Therapeutics, Inc. is an American company that aims to develop life-changing therapies for rare diseases. The company's mission is to help millions of patients in urgent need. The company was founded by Adam Rosenthal, who has been the CEO since incorporation. | 6 years |
Paul Hastings | M | 64 | 13 years | |
Laura Brege | F | 66 | 13 years | |
Lauren Riker | F | 45 | 12 years | |
Sherry Aulin | F | 41 | 13 years | |
Elizabeth Garofalo | M | 66 | 3 years | |
Clarence Machado | M | 60 | 4 years | |
Daniela Salvemini | F | - |
Biointervene, Inc.
![]() Biointervene, Inc. Pharmaceuticals: MajorHealth Technology Biointervene, Inc. operates as a biopharmaceutical company. The company was founded by Gary J. Bennett and Daniela Salvemini in 2014 and is headquartered in San Diego, CA. | - |
James Ford | M | - | 29 years | |
Devin Quinlan | M | - |
MPM BioImpact, Inc
![]() MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | 6 years |
Andrea DiFabio | F | 55 | 2 years | |
Rami Rahal | M | - |
MPM BioImpact, Inc
![]() MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | 2 years |
Dawn Svoronos | F | 70 | 8 years | |
Jodi Regts | F | - | 9 years | |
Edward Hurwitz | M | 60 |
Biointervene, Inc.
![]() Biointervene, Inc. Pharmaceuticals: MajorHealth Technology Biointervene, Inc. operates as a biopharmaceutical company. The company was founded by Gary J. Bennett and Daniela Salvemini in 2014 and is headquartered in San Diego, CA.
MPM BioImpact, Inc
![]() MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | 7 years |
Mark Kronenfeld | M | 69 | 11 years | |
Steven Gannon | M | 62 | 9 years | |
Robin Sherrington | M | 63 | 23 years | |
Brian Goodman | M | - |
MPM BioImpact, Inc
![]() MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | 5 years |
Graham Rivers | M | - | 26 years | |
Christian Desmarteaux | M | - |
MPM BioImpact, Inc
![]() MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | 3 years |
Michael Rogawski | M | - | - | |
H. Robert Horvitz | M | - |
MPM BioImpact, Inc
![]() MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | 19 years |
Andrew Scharenberg | M | - |
MPM BioImpact, Inc
![]() MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | 5 years |
Patrick Baeuerle | M | 66 |
MPM BioImpact, Inc
![]() MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | 9 years |
Thomas Barnes | M | - |
MPM BioImpact, Inc
![]() MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | 4 years |
Briggs Morrison | M | 65 |
MPM BioImpact, Inc
![]() MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | 9 years |
Beth Seidenberg | M | 67 |
Star Therapeutics, Inc.
![]() Star Therapeutics, Inc. BiotechnologyHealth Technology Star Therapeutics, Inc. is an American company that aims to develop life-changing therapies for rare diseases. The company's mission is to help millions of patients in urgent need. The company was founded by Adam Rosenthal, who has been the CEO since incorporation. | - |
Uciane Scarlett | M | - |
MPM BioImpact, Inc
![]() MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | 3 years |
Susan Mesco | F | - | 9 years | |
Elizabeth Stoner | M | 73 |
MPM BioImpact, Inc
![]() MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | 17 years |
Detlev Biniszkiewicz | M | 56 |
MPM BioImpact, Inc
![]() MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | 3 years |
Pankaj Bhargava | M | 54 |
MPM BioImpact, Inc
![]() MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | 3 years |
Mark Timney | M | 58 |
Blade Therapeutics, Inc.
![]() Blade Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Blade Therapeutics, Inc. offers anti-fibrotic therapies to meet unserved patient needs. Its product portfolio is to address various fibrotic diseases and their underlying pathophysiology. The company was founded by Hal Dietz and Wendye R. Robbins and is headquartered in South San Francisco, CA. | 4 years |
Ethel M. Koczon | F | - | 9 years | |
Matt Roden | M | 53 |
MPM BioImpact, Inc
![]() MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | 4 years |
Charles Reinhart | M | 63 | 13 years | |
Greg Sieczkiewicz | M | - |
MPM BioImpact, Inc
![]() MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | 9 years |
Kellie Neville | F | - |
MPM BioImpact, Inc
![]() MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | 4 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Simon Pimstone | M | 56 | 28 years | |
Frank Holler | M | 67 | 25 years | |
Mark J. Fitzpatrick | M | 61 | 6 years | |
David Stack | M | 72 |
MPM BioImpact, Inc
![]() MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | 16 years |
Michael Hayden | M | 72 | 26 years | |
Rajkumar Kannan | M | 61 | 2 years | |
James Shannon | M | 68 |
Cerimon Pharmaceuticals, Inc.
![]() Cerimon Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Cerimon Pharmaceuticals, Inc. developed and distributed biopharmaceutical products. It developed Simulect, a monoclonal antibody for the treatment of moderate-to-severe and steroid-refractory ulcerative colitis; diclofenac sodium, a non-steroidal anti-inflammatory drug that are used to treat various pains, included pain due to musculoskeletal injuries and lower back pain; and topical diclofenac sodium patch products. The company was founded by Paul J. Sekhri, Ansbert Gadicke, and Luke Evnin in November 2004 and was headquartered in South San Francisco, CA. | 1 years |
Evan Stein | M | 77 | 8 years | |
John W. Vander Vort | M | 59 |
MPM BioImpact, Inc
![]() MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | - |
Paul Sekhri | M | 66 |
Cerimon Pharmaceuticals, Inc.
![]() Cerimon Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Cerimon Pharmaceuticals, Inc. developed and distributed biopharmaceutical products. It developed Simulect, a monoclonal antibody for the treatment of moderate-to-severe and steroid-refractory ulcerative colitis; diclofenac sodium, a non-steroidal anti-inflammatory drug that are used to treat various pains, included pain due to musculoskeletal injuries and lower back pain; and topical diclofenac sodium patch products. The company was founded by Paul J. Sekhri, Ansbert Gadicke, and Luke Evnin in November 2004 and was headquartered in South San Francisco, CA. | 5 years |
peter vlasselaer | M | - |
True North Therapeutics, Inc.
![]() True North Therapeutics, Inc. BiotechnologyHealth Technology True North Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of first-in-class product candidates for complement-mediated diseases. The company was founded by Nancy E. Stagliano in 2013 and is headquartered in South San Francisco, CA.
Blade Therapeutics, Inc.
![]() Blade Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Blade Therapeutics, Inc. offers anti-fibrotic therapies to meet unserved patient needs. Its product portfolio is to address various fibrotic diseases and their underlying pathophysiology. The company was founded by Hal Dietz and Wendye R. Robbins and is headquartered in South San Francisco, CA. | 6 years |
Mark Leuchtenberger | M | 67 | 1 years | |
Koji Shinozaki | M | - |
MPM BioImpact, Inc
![]() MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | 3 years |
Vincent J. Miles | M | 73 | 3 years | |
Jeff Ajer | M | 61 |
True North Therapeutics, Inc.
![]() True North Therapeutics, Inc. BiotechnologyHealth Technology True North Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of first-in-class product candidates for complement-mediated diseases. The company was founded by Nancy E. Stagliano in 2013 and is headquartered in South San Francisco, CA. | - |
Richard Scranton | M | 57 | 9 years | |
Mark Walters | M | 69 | 5 years | |
Clarissa Desjardins | M | 57 | - | |
Yvonne Greenstreet | M | 61 | 9 years | |
Peter Traber | M | 69 | 3 years | |
Y. Paul Goldberg | M | 64 | 18 years | |
Peter van Vlasselaer | M | 64 |
True North Therapeutics, Inc.
![]() True North Therapeutics, Inc. BiotechnologyHealth Technology True North Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of first-in-class product candidates for complement-mediated diseases. The company was founded by Nancy E. Stagliano in 2013 and is headquartered in South San Francisco, CA. | - |
Shinichiro Fuse | M | - |
MPM BioImpact, Inc
![]() MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | 5 years |
David Wheadon | M | 66 |
Smithkline Beecham Pharmaceuticals Ltd.
| 8 years |
Graham Parry | M | - |
True North Therapeutics, Inc.
![]() True North Therapeutics, Inc. BiotechnologyHealth Technology True North Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of first-in-class product candidates for complement-mediated diseases. The company was founded by Nancy E. Stagliano in 2013 and is headquartered in South San Francisco, CA. | 3 years |
Dror Brandwein | M | - | 3 years | |
Drew Enamait | M | 50 | 6 years | |
Murray Stewart | M | 63 | 17 years | |
David Alan Goodkin | M | - | - | |
lee Giguere | M | 43 | 2 years | |
Nicholas McGrath | M | - |
MPM BioImpact, Inc
![]() MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | 3 years |
Ken Greenberg | M | - |
MPM BioImpact, Inc
![]() MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | 3 years |
Michael Tarnow | M | 79 | 22 years | |
John Thero | M | 63 | 6 years | |
Richard Scheller | M | 70 | 5 years | |
Ansbert Gadicke | M | 66 | 2 years | |
Henrik Rasmussen | M | 65 | 5 years | |
James Welch | M | 66 |
Cerimon Pharmaceuticals, Inc.
![]() Cerimon Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Cerimon Pharmaceuticals, Inc. developed and distributed biopharmaceutical products. It developed Simulect, a monoclonal antibody for the treatment of moderate-to-severe and steroid-refractory ulcerative colitis; diclofenac sodium, a non-steroidal anti-inflammatory drug that are used to treat various pains, included pain due to musculoskeletal injuries and lower back pain; and topical diclofenac sodium patch products. The company was founded by Paul J. Sekhri, Ansbert Gadicke, and Luke Evnin in November 2004 and was headquartered in South San Francisco, CA. | 4 years |
Mohammad Azab | M | 68 | 21 years | |
Richard Sykes | M | 79 | 7 years | |
John David Coombe | M | 79 | 5 years | |
Michèle Barzach | M | - | 7 years | |
Frank Baldino | M | 71 |
MPM BioImpact, Inc
![]() MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | - |
Scott Braunstein | M | 60 | 3 years | |
Chaime Orlev | M | 53 | 6 years | |
John Scarlett | M | 73 | 6 years | |
Johnston L. Evans | M | 76 | 7 years | |
Dennis L. Winger | M | 77 | 5 years | |
Karen G. Corraini | F | 69 | 14 years | |
Ashley L. Dombkowski | M | - |
MPM BioImpact, Inc
![]() MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | 11 years |
Alex Howarth | M | 55 | 10 years | |
James Tobin | M | 79 | 1 years | |
Julian Heslop | M | 70 | 13 years | |
Anthony Adam Rosenberg | M | 71 |
MPM BioImpact, Inc
![]() MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | 5 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 67 | 67.00% |
Canada | 22 | 22.00% |
United Kingdom | 11 | 11.00% |
Ireland | 1 | 1.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Gary Patou
- Personal Network